I
Inna Friesen
Publications - 4
Citations - 337
Inna Friesen is an academic researcher. The author has contributed to research in topics: Myelodysplastic syndromes & Medicine. The author has an hindex of 2, co-authored 2 publications receiving 316 citations.
Papers
More filters
Journal ArticleDOI
Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Felicitas Thol,Inna Friesen,Frederik Damm,Haiyang Yun,Eva M. Weissinger,Jürgen Krauter,Katharina Wagner,Anuhar Chaturvedi,Amit Sharma,Martin Wichmann,Gudrun Göhring,Christiane Schumann,Gesine Bug,Oliver G. Ottmann,Wolf-Karsten Hofmann,Brigitte Schlegelberger,Michael Heuser,Arnold Ganser +17 more
TL;DR: It is suggested that ASXL1 mutations are frequent molecular aberrations in MDS that predict an adverse prognostic outcome and Screening of patients for AS XL1 mutations might be useful for clinical risk stratification and treatment decisions in the future.
Journal ArticleDOI
Rare occurrence of DNMT3A mutations in myelodysplastic syndromes
Felicitas Thol,Claudia Winschel,Andrea Ludeking,Haiyang Yun,Inna Friesen,Frederik Damm,Katharina Wagner,Juergen Krauter,Michael Heuser,Arnold Ganser +9 more
TL;DR: In patients with myelodysplastic syndromes, DNMT3A mutations occur at a low frequency and may be a risk factor for leukemia progression and no difference in global DNA methylation levels between the two groups was seen.
Journal ArticleDOI
[Treatment of tuberculosis: what is new?]
Thomas Theo Brehm,Niklas Köhler,Stefan Schmiedel,Elena Terhalle,Barbara Kalsdorf,Janne Kandulla,Jan Heyckendorf,Martin Kuhns,Inna Friesen,Christoph Lange +9 more
TL;DR: The Therapie der multiresistenten/rifampicinresistenten Tuberkulose (MDR-/RR-TB) as mentioned in this paper has been verkürzt auf sechs Monate verkurzt und is damit genau so lang, wie die in Deutschland verfügbare Standardtherapie.
Journal ArticleDOI
Long-term treatment outcomes in multidrug-resistant tuberculosis.
Christina Maier,Dumitru Chesov,Dagmar Schaub,Barbara Kalsdorf,Sönke Andres,Inna Friesen,Maja Reimann,Christoph Lange +7 more
TL;DR: In this article , the authors compared long-term treatment outcomes derived from individual patient follow-up with treatment outcomes defined by WHO-2013, WHO-2021 and the Tuberculosis Network European Trials Group-2016.